The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
The company forces you to get prior authorization annually from your provider to continue getting the same maintenance medication for a chronic condition. The company has approved for the same ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback